Medical Properties Trust (NYSE:MPW) Price Target Raised to $5.00

Medical Properties Trust (NYSE:MPW) had its price objective raised by investment analysts at Truist Financial from $4.50 to $5.00 in a research note issued to investors on Thursday, Benzinga reports. The firm currently has a “hold” rating on the real estate investment trust’s stock. Truist Financial’s price target would indicate a potential downside of 0.40% from the company’s current price.

Other analysts have also recently issued research reports about the company. Deutsche Bank Aktiengesellschaft upgraded Medical Properties Trust from a “sell” rating to a “hold” rating and upped their price objective for the company from $2.00 to $5.00 in a research report on Wednesday, April 17th. Colliers Securities cut Medical Properties Trust from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $10.00 to $4.25 in a research report on Wednesday, April 10th. BNP Paribas upgraded Medical Properties Trust from a “neutral” rating to an “outperform” rating and set a $6.00 price target for the company in a research report on Friday, March 1st. Royal Bank of Canada restated a “sector perform” rating and issued a $5.00 price target on shares of Medical Properties Trust in a research report on Tuesday, May 14th. Finally, StockNews.com lowered Medical Properties Trust from a “hold” rating to a “sell” rating in a research note on Saturday, May 18th. Five investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Medical Properties Trust presently has an average rating of “Hold” and a consensus price target of $5.80.

Medical Properties Trust Stock Performance

Medical Properties Trust stock traded up $0.04 during mid-day trading on Thursday, reaching $5.02. 1,989,734 shares of the stock traded hands, compared to its average volume of 21,841,459. The stock has a market capitalization of $3.01 billion, a PE ratio of -2.27, a price-to-earnings-growth ratio of 0.68 and a beta of 1.19. The company has a debt-to-equity ratio of 1.48, a current ratio of 3.10 and a quick ratio of 2.26. Medical Properties Trust has a 12-month low of $2.92 and a 12-month high of $10.74. The business’s 50-day moving average is $4.65 and its 200-day moving average is $4.35.

Institutional Investors Weigh In On Medical Properties Trust

Institutional investors and hedge funds have recently bought and sold shares of the company. Lindbrook Capital LLC raised its position in shares of Medical Properties Trust by 112.1% in the 1st quarter. Lindbrook Capital LLC now owns 7,225 shares of the real estate investment trust’s stock worth $34,000 after acquiring an additional 3,819 shares in the last quarter. Future Financial Wealth Managment LLC bought a new position in shares of Medical Properties Trust in the 1st quarter worth $38,000. Tucker Asset Management LLC raised its position in shares of Medical Properties Trust by 2,447.6% in the 3rd quarter. Tucker Asset Management LLC now owns 7,974 shares of the real estate investment trust’s stock worth $43,000 after acquiring an additional 7,661 shares in the last quarter. Cetera Trust Company N.A bought a new position in shares of Medical Properties Trust in the 4th quarter worth $43,000. Finally, Fidelis Capital Partners LLC bought a new position in shares of Medical Properties Trust in the 1st quarter worth $43,000. 71.79% of the stock is owned by institutional investors.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.